About Us
Empowering Oncology with Artificial Intelligence
At KeyZell Deep Tech, we are pioneers in advanced technological solutions for cancer diagnosis and treatment. Our mission is to transform healthcare by integrating artificial intelligence into hospitals, clinics, and health systems, enhancing diagnostic precision, personalizing treatments, and optimizing resources.
As a subsidiary of KeyZell Holding, we combine years of expertise in oncology with cutting-edge technology to deliver tools that empower medical professionals and improve patients’ quality of life.
Our Mission
To revolutionize cancer care through innovative solutions that improve medical outcomes and reduce costs.
We strive to make technology a key ally in clinical decision-making, ensuring that every patient receives the best possible treatment.
Our Vision
A future where every diagnosis is accurate, and every treatment is optimized for each patient.
Our goal is to become a global leader in technology applied to oncology, setting the standard for artificial intelligence in personalized medicine.
Our Values
Innovation
Developing disruptive tools that redefine standards in oncology.
Patient-Centered Approach
Placing the patient at the core of all our solutions, prioritizing their well-being and quality of life.
Collaboration
Building strategic alliances with hospitals, governments, and research centers to expand the impact of our technologies.
Excellence
Delivering the highest level of quality in every solution, supported by scientific and clinical validations.
Our Facilities and Global Reach
International Presence
Offices in Spain, the United Kingdom, Mexico, Australia, and Thailand.
Strategic Collaborations
Partnerships with leading hospitals and public health systems to deploy our solutions globally.
Certifications and Recognitions
- CE Certification:
Meeting the highest quality standards in healthcare technology.
- ISO13485:
In progress.
- Member of BME Pre-Market Environment:
Recognized for our business strength and future potential.
- Finalist in the Santander X Global Challenge 2023:
Celebrated for our innovation in technology applied to oncology.
Join Our Mission
Whether you’re a hospital, investor, or researcher, together we can transform the future of oncology.
